Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... Beyond 14 days, there were no reactive or grayzone HBsAg tests that could be attributed to recent HBV vaccination.
The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Precision BioSciences (NASDAQ:DTIL) added ~6% in the premarket on Wednesday after the gene therapy developer announced ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...